DeLuca Teresa Insider Trading Activity

Average Profitability
44.55%
Insider Buys Quantity
3
Insider Buys Sum
$249,900.00
Insider Sells Quantity
7
Insider Sells Sum
$1.51M

Insider Activity of DeLuca Teresa

According to the SEC Form 4 filings, DeLuca Teresa, being in a position of

  1. director at LifeStance Health Group, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 27941 share for $345,093,
    over all time since 2026-08-13, has bought 0 shares, and sold 27941 share for $345,093.

Biography of DeLuca Teresa

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$161,213133
Sells
$345,093267

Comparison of Insiders on Amount of Buys and Sells

2026-08-18PurchaseSurgery Partners, Inc.
SGRY
director
11,250
0.0087%
$14.33$161,213-0.39%
2026-08-14SaleLifeStance Health Group, Inc.
LFST
director
7,500
0.002%
$12.68$95,100+0.64%
2026-08-13SaleLifeStance Health Group, Inc.
LFST
director
20,441
0.0053%
$12.23$249,993+2.13%
2025-08-11SaleSurgery Partners, Inc.
SGRY
director
20,018
0.0156%
$22.74$455,209-31.4%
2022-03-24SaleSurgery Partners, Inc.
SGRY
1,535
0.0017%
$53.50$82,123-40.82%
2021-08-10PurchaseSurgery Partners, Inc.
SGRY
director
4,000
0.0051%
$46.70$186,800+0.59%
2021-06-09SaleSurgery Partners, Inc.
SGRY
director
10,070
0.0146%
$63.67$641,157-22.19%
2021-06-08SaleSurgery Partners, Inc.
SGRY
director
5,266
0.0077%
$63.05$332,021-21.06%
2020-12-14SaleSurgery Partners, Inc.
SGRY
director
2,000
0.0042%
$27.15$54,300+70.87%
2020-12-04SaleSurgery Partners, Inc.
SGRY
director
1,830
0.0038%
$27.75$50,783+62.93%
2020-09-10SaleSurgery Partners, Inc.
SGRY
director
6,000
0.012%
$21.00$126,000+93.49%
2020-08-10SaleSurgery Partners, Inc.
SGRY
director
10,634
0.0222%
$20.60$219,060+84.98%
2019-09-06PurchaseSurgery Partners, Inc.
SGRY
director
2,000
0.0042%
$6.65$13,300+88.5%
Total: 13
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.